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Abstract
Epidemiological studies of group A streptococcus (GAS) have noted an inverse relationship between SpeB expression and
invasive disease. However, the role of SpeB in the course of infection is still unclear. In this study we utilize a SpeB-negative
M1T1 clinical isolate, 5628, with a naturally occurring mutation in the gene encoding the regulator RopB, to elucidate the
role of RopB and SpeB in systemic virulence. Allelic exchange mutagenesis was used to replace the mutated ropB allele in
5628 with the intact allele from the well characterized isolate 5448. The inverse allelic exchange was also performed to
replace the intact ropB in 5448 with the mutated allele from 5628. An intact ropB was found to be essential for SpeB
expression. While the ropB mutation was shown to have no effect on hemolysis of RBC’s, extracellular DNase activity or
survival in the presence of neutrophils, strains with the mutated ropB allele were less virulent in murine systemic models of
infection. An isogenic SpeB knockout strain containing an intact RopB showed similarly reduced virulence. Microarray
analysis found genes of the SpeB operon to be the primary target of RopB regulation. These data show that an intact RopB
and efficient SpeB production are necessary for systemic infection with GAS.
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Introduction
Streptococcus pyogenes (group A streptococcus; GAS) is a Gram-
positive, human-specific pathogen responsible for over 500,000
deaths each year [1]. Severe invasive GAS infections such as
necrotizing fasciitis account for approximately 30% of these
deaths, and the incidence of such acute conditions has been on the
rise since the mid 1980’s [2]. This resurgence has been paralleled
by the emergence of a globally disseminated GAS cone belonging
to serotype M1T1 [3–5]. While the M1T1 GAS has become the
most common cause of streptococcal pharyngitis, this clone is also
overrepresented in cases of severe invasive disease [6,7].
Studies of M1T1 clinical isolates from invasive disease cases
have revealed an inverse relationship between expression of the
extracellular cysteine protease SpeB and clinical severity [8]. The
existence of a SpeB-negative invasive phenotype has been
hypothesized that results from mutations in the regulator covR/
S [9]. SpeB is a secreted cysteine protease initially expressed as
40 kDa zymogen which is then converted to the 28 kDa active
form by autocatalytic processing [10]. SpeB is known to cleave
numerous host proteins including components of the extracellular
matrix, cytokine precursors, immunoglobulins and antimicrobial
peptides [11–13], which could interfere with host immune
functions. However, SpeB has also been shown to cleave a range
of GAS proteins such as the fibrinogen-binding M1 protein
[14,15], various superantigens [16,17], the secreted plasminogen
activator streptokinase [18] as well as the DNase Sda1 [17], and
thus possibly interfere with the proven virulence functions of these
bacterial factors. The precise role(s) of SpeB throughout the course
of infection are undoubtedly complex, and not surprisingly,
different studies using different in vivo animal models have
produced seemingly contradictory results [19–21].
In this study we examined the effect of a natural mutation in the
gene encoding the regulator RopB (also known as Rgg [22])
identified in a SpeB-negative GAS clinical isolate. RopB is a GAS
transcriptional regulator that has been shown to be essential for
expression of SpeB and binds directly to the promoter region of
speB [23,24]. In studies performed in different GAS serotype
strains, RopB has variably been suggested to be involved in the
regulation of other GAS genes including those associated with
metabolism of non-glucose carbohydrates and amino acids
[25,26], response to thermal and oxidative stress [25,27] and the
expression of virulence factors including DNases (MF-1 and MF-3)
and hemolysins (streptolysin S and streptolysin O) [26,28,29].
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have yielded differing results. A study utilizing a zebrafish
intramuscular infection model with serotype M5 GAS showed
that inactivation of RopB resulted in decreased virulence [30],
whereas a study utilizing a murine intraperitoneal infection model
with serotype M49 GAS showed that inactivation of RopB
resulted in increased virulence [27].
While such global differences in virulence effects could in part
result from the differing animal models used, it may also reflect
strain-specific variation in the RopB regulon. For example,
separate studies have shown ropB mutation to have either no
effect on hemolysis and DNase activity or, alternatively, to increase
expression of hemolysin and DNase-encoding genes and the
associated phenotypic activities [23,26]. This strain-specific
variation is highlighted in a recent work by Dmitriev et al. [29]
that shows inter- and intra-serotypic variation in the transcriptome
of ropB mutant GAS, with only members of the SpeB operon being
commonly regulated in all strains tested.
It is in the light of the current uncertainty surrounding RopB
and its role in virulence that we sought to investigate the role of
this transcriptional regulator in the serotype M1T1 GAS
background that is the leading agent of severe human infection.
This analysis begins with a naturally-occuring mutation in ropB
identified in one such strain.
Materials and Methods
Bacterial strains, media and growth conditions
The M1T1 GAS clinical isolates, 5448 and 5628, used in this
study have been previously described [31]. Both 5448 and 5628
are speA-positive M1T1 strains that were isolated from patients
with STSS that were recruited through an ongoing population-
based surveillance for invasive GAS infections in Ontario,
Canada. Both strains were determined to be derived from the
same clone as detailed elsewhere [3]. GAS strains were grown in
Todd-Hewitt broth containing 1% yeast extract (THY), or on
Todd-Hewitt agar plates (THA). Escherichia coli were grown in
Luria-Bertani broth (LB) or on Luria-Bertani agar (LA). For
antibiotic selection, erythromycin (Erm) was used at 5 mg/ml for
GAS and 500 mg/ml for E. coli.
Allelic exchange mutagenesis was performed essentially as
previously described [32]. The ropB allele plus upstream and
downstream flanking regions was amplified from 5448 or 5628
using the primers RopB-F-BamHI (59-CAG GAT CCC TCA TTT
CAG TTG ACA AGA AAC-39) and RopB-R-XbaI (59-CGC TCT
AGA TAC CAA AAG GCT AGA CCT CTG-39). The PCR
products and temperature sensitive vector pHY304 were ligated
using T4 ligase to create the plasmids pHY5448RopB and
pHY5628RopB. The plasmid pHY5628RopB was transformed
into GAS strain 5448 and the plasmid pHY5448RopB was
transformed into GAS strain 5628, and Erm
r transformants were
grown at the permissive temperature for plasmid replication (30uC).
Single-crossoverchromosomal insertions wereselectedbyshiftingto
the nonpermissive temperature (37uC) while maintaining Erm
selection. Single crossover colonies were then grown in the absence
of antibiotic selection at 30uC and Erm
s colonies were then screened
for the presence of the appropriate ropB allele using DNA sequence
analysis. Confirmed allelic exchange mutants were designated
5448R2 (5448 containing the mutant ropB allele from 5628) and
5628R+ (5628 containing the wildtype (WT) ropB allele from 5448).
SpeB activity assays
Cysteine protease activity assays were performed as described
by Collin et al. [33]. GAS strains were grown overnight at 37uC.
Cultures were then diluted 1:50 and grown for 17 h at 37uC. The
cultures were centrifuged at 32006g, and the supernatants sterile-
filtered through 0.2 mm syringe-driven filters (Whatman). 200 ml
of filtered supernatant was mixed with 200 ml of activation buffer
(1 mM EDTA, 20 mM DTT in 0.1 M sodium acetate buffer,
pH 5.0) and incubated for 30 min at 40uC. 400 ml of 2% (w/v)
azocasein in activation buffer was then added and incubated for a
further 1 h at 40uC. Trichloro-acetic acid was then added to a
final concentration of 15% (w/v) and thoroughly mixed. The
mixture was then centrifuged at 15,0006g for 5 min and the
OD366 of the supernatant was then measured to indicate cleavage
of the azocasein by SpeB.
SpeB Western blot
For Western blot analysis, bacterial cultures were grown to late
stationary phase (17 h) and pelleted by centrifugation at 3,2006g
for 10 min. The supernatants were sterile-filtered through
0.22 mm syringe-driven filters (Millipore). Supernatants were
diluted 1:8 and 10 ml of each sample was run on a 10% Bis-Tris
Gel with MOPS running buffer (Invitrogen). Proteins were then
transferred to a Nitrocellulose membrane (Invitrogen) by use of a
Trans-Blot SD semi-dry transfer cell (BioRad) for 1 h at 20 V.
The presence of SpeB in culture supernatants was detected using
primary rabbit anti-SpeB diluted 1:1,000 for 1.5 h. Following
subsequent washing, the membrane was incubated with a
secondary goat anti-rabbit-HRP conjugate diluted 1:10,000 for
1 h. SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific) was used to expose autoradiography film as per the
manufacturer’s instructions.
Hemolytic activity assay
Fresh, heparinized human blood from healthy volunteers was
washed twice with sterile PBS and resuspended to a final
concentration of 2% (v/v) in PBS. Bacterial cultures were grown
to mid-log phase (OD600=0.4), pelleted by centrifugation at
3,2006g and the supernatants sterile-filtered through 0.22 mm
syringe-driven filters (Millipore). 100 ml of blood solution was mixed
with 100 ml of serially diluted supernatant. The plates were
incubatedfor1 hat37uC,then 1 hat4uC.Followingcentrifugation
at 1,5006g for 10 min, 100 ml was transferred into a fresh 96-well
flat bottom plate and the absorbance at 405 nm was recorded.
DNase activity assays
DNase assays were performed as previously described [34,35].
Briefly, GAS strains were grown to mid-log phase (OD600=0.4),
and the supernatants collected by centrifugation at 32006g. 2.5 ml
of bacterial supernatant was added to 7.5 ml of calf thymus DNA
(1 mg/ml) and 40 ml of DNase buffer (3 mM MgCl2,3 m M
CaCl2, 300 mM Tris; pH 7.4). The reaction was incubated for
5 min at 37uC and then stopped by the addition of 12.5 ml 0.33 M
EDTA (pH 7.3). The relative DNA degradation was then
compared by gel electrophoresis on a 1% agarose gel.
Neutrophil killing assays
Human neutrophils were isolated from venous blood of healthy
volunteers using the PolyMorphPrep kit as per the manufacturer’s
instructions (Axis-Shield, Norway). In 96-well plates, we mixed
2610
5 neutrophils and 2610
4 colony forming units (cfu) of
logarithmic phase GAS in RPMI containing 2% heat-inactivated
autologous plasma in a total volume of 200 ml. The plates were
centrifuged at 5006g for 5 min and incubated at 37uCi n5 %C O 2
for 30 min. The neutrophils were then hypotonically lysed in
H2O, serially diluted and plated on THA. The plates were
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containing bacteria but no neutrophils were used to determine
survival. Percentage survival was calculated as [cfu/ml experi-
mental well]/[cfu/ml control well]6100%.
In vivo SpeB switching studies
GAS strain 5628R+ was grown to mid-log phase (OD600=0.4),
pelleted by centrifugation at 3,2006g and washed twice with sterile
PBS. Bacteria were then resuspended in PBS at a final
concentration of 1610
9cfu/ml. 100 ml of bacterial suspension
(1610
8 cfu) was injected subcutaneously into the flank of 10 week
old C57BL6/J mice. Three days post-infection, bacteria were
recovered from the lesion and screened for SpeB status using the
skim-milk agar method as previously described [36].
Tissue cage implantation and in vivo bacterial growth
To obtain in vivo-derived RNA for microarray analysis, a
previously described subcutaneous murine Teflon chamber model
was used [31]. Approximately 10
8 cfu of bacteria were injected in
sterile Teflon chambers that had been surgically inserted under the
skin of age-matched female BALB/c mice. After 24 h, bacteria
were collected, tested for purity and phenotypic homogeneity on
blood agar plates and Columbia-casein agar plates, respectively.
Only pure isolates with homogeneous protease activity (either
positive or negative) were further selected for RNA extraction.
Selected isolates recovered from Teflon chambers were centri-
fuged, and their pellets were washed twice in PBS, sheared with
beads (QBiogene), then processed for RNA extraction according
to the RNEasey protocol (Qiagen).
Expression microarrays
For transcriptome analysis, we used oligomer-based microarrays
printed in the Molecular Resource Center at the University of
Tennessee Health Science Center. Each array consists of
duplicates of 2,328 oligomers (70-mers) that represent all ORFs
in M1 GAS, strain SF370 (GenBank accession # NC_002737) in
addition to oligomers representing ORFs from prophages in
strains MGAS8232 (GenBank accession# NC_003485) and
MGAS315 (GenBank accession # NC_004070). The arrays also
contained positive and negative controls of streptococcal ribosomal
DNA and alien DNA (Stratagene), respectively.
cDNA preparation and microarray hybridization
Bacterial RNA was treated with DNase Turbo (Ambion) for 1 h to
remove any genomic DNA contamination, then converted it to
dendrimer-labeled cDNA using the 3DNA Array 900TM kits
(Genisphere, http://www.genisphere.com/array_detection_900.
html) following the manufacturer’s protocol. Equal amounts of
dendrimer-labeled cDNA from different pairs of isolates were mixed,
applied to the glass microarrays, and incubated for 16 h. After this
first hybridization, the arrays were washed, labeled with a mixture of
Alexa Fluor 546 and Alexa Fluor 647 (Genisphere), incubated for
3 h, washed again, then scanned bv GenePix 4000B scanner (Axon
Instruments, Inc.) We followed a cyclic design that allowed us to
compare every condition to each other at least twice, and guaranteed
dye swapping to eliminate effects of non-specific binding.
Analysis of microarray data
To analyze the microarray data, GenePixPro 4.0 software
(Axon Instruments, Inc.) was used for image processing,
fluorescent normalization and spot finding, then GeneSpring
GX 7.3.1 (Agilent Technologies) was used for normalization,
statistical analysis, clustering analysis and gene-list generation. All
primary microarray data were submitted to the NCBI Gene
Expression Omnibus (GEO) in accordance with MIAME
standards (GEO accession # GSE13656).
Murine systemic infection models
GAS strains were grown to mid-log phase (OD600=0.4),
pelleted by centrifugation at 3,2006g and washed twice with
sterile PBS. For intravenous challenge, bacteria were then
resuspended in PBS at a final concentration of 1610
9cfu/ml.
200 ml of bacterial suspension (2610
8 cfu) was injected into the
lateral tail vein of 10 week old C57BL6/J mice. For intraperitoneal
infection, the bacteria were resuspended at a concentration of
2.5610
8 cfu/ml in PBS containing 5% (w/v) mucin. 200 mlo f
bacterial suspension (5610
7 cfu) was injected into the peritoneal
cavity of C57BL6/J mice. For both experiments, the mice were
monitored for 10 days and deaths recorded every 24 h.
Results
Sequence analysis of clinical isolate 5628 reveals intact
speB and covR/S but mutation in ropB
M1T1 GAS clinical isolate 5628 was found on screening to lack
SpeB activity by azocasein assay. DNA sequencing was performed
using primers listed in Table 1. No mutations were found in the
strain 5628 in the speB gene nor in the covR/S locus, which has
been previously linked to loss of SpeB expression [37,38]. Further
sequencing was performed on the previously described regulators
luxS, rofA, ropA and ropB [24,39–41]. This analysis revealed a point
mutation in ropB, leading to truncation of RopB at amino acid 170
of the 280 amino acid protein (Fig. 1A). The truncation of RopB
suggested that this may be the cause of lack of SpeB expression in
this strain.
Repair of the 5628 ropB allele restores SpeB expression
and activity
Western blot detected SpeB in overnight culture supernatants of
5628R+, containing the intact ropBallele,butnotintheclinicalisolate
5628 nor the isogenic mutant 5628RDSpeB, containing the intact
ropB allele but lacking speB (Fig. 1B). This expression correlated with a
restoration of extracellular protease activity as detected by azocasein
degradation assay (Fig. 1C). Protease activity was abrogated by the
addition of the cysteine protease inhibitor E64. These data
demonstrated that the ropB point mutation was indeed responsible
for the lack of SpeB expression in the clinical isolate 5628.
RopB mutation does not affect bacterial growth,
hemolysis, DNase activity or resistance to neutrophil
killing
GAS strain 5628 and its isogenic mutants 5628R+ and
5628RDSpeB were grown in THB, and the OD600 was measured
over time. No significant difference was found among the growth
rates of the three bacterial strains (Fig. 2A). Hemolysis assays were
performed to determine the effect of ropB mutation on the cytolytic
ability of GAS. No significant difference was seen in hemolytic
activity among strains containing the WT or mutated ropB allele
(Fig. 2B). Extracellular DNase activity of mid-log phase bacteria
and GAS resistance to neutrophil killing were also unaffected by
mutation in ropB (Fig. 2C and 2D).
SpeB-positive bacteria revert to a SpeB-negative
phenotype on subcutaneous infection
C57BL6/J mice were subcutaneously infected with the SpeB-
positive strain 5628R+. Three days post-infection, bacteria were
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skim-milk agar method. While the inoculum was 100% SpeB-
positive, bacterial populations recovered from the lesions of
individual mice were found to be 2%, 4%, 6%, 8%, and 24%
SpeB-negative. Five representative colonies were picked, and the
covR/S locus was sequenced in each of them. All colonies
sequenced were found to have substitution mutations in covR/S
resulting in truncation of CovS. This finding reveals that when
SpeB-negative colonies are selected for in vivo, this selection is
predominantly a phenomenon associated with CovR/S inactiva-
Table 1. Primers used for sequencing the ropB locus
(including speB), the covR/S locus, luxS, rofA and ropA.
Primer name Sequence (59–39)
RopB-F1 GACTGTTCGTTAGAAAGCCA
RopB-F2 CTCCTGATACGATGATAA
RopB-F3 AAAGTTTTCTTTCAAGGC
RopB-F4 CTTTGATTTGTTCGACAT
RopB-F5 TACCATGAATGGTAATAG
RopB-F6 TATCTCACTACCATTTTGC
RopB-F7 TGAGTTTCTCTTTATTAG
RopB-F8 GAACGGTGTTGTGTGTCT
RopB-R9 AGTCACCCATTGATAAAG
RopB-R10 AGGCGGCTTCAACGGTTA
RopB-R11 AGACTACACTTACACACT
RopB-R12 ATCCAAAAATCAGCAGCTATC
RopB-R13 TTAACAAAATGAGAACGG
RopB-R14 TGATAGTCGCTTATGATA
RopB-R15 CATATTGACAAACATCCGAATCG
RopB-R16 GCTGTTGAGATAAACTAC
RopB-R17 CTAGACCTCTGCTCACTAG
CovRS-F1 GCTATTCCGGTACAGGTGT
CovRS-F2 GTCAATGGTCGTGAAGGGT
CovRS-F3 GATGTCTATATTCGTTATCTCC
CovRS-F4 GATGATTTTTACCACAGATAAC
CovRS-F5 GCATATTGGTCTCTTACAAC
CovRS-F6 GCAAATTGTAGATGGGTATCA
CovRS-R7 GCGGAAAATAGCACGAATAC
CovRS-R8 AGGCAATCAGTGTAAAGGCA
CovRS-R9 CTTGTGCCAAATAACTCAACA
CovRS-R10 ATCAAAAGCCTGCTCAAATGA
CovRS-R11 CTTTCATGTCATCCATCATTG
CovRS-R12 TTGCTCTCGTGTGCCATCT
LuxS-F1 GCAGCTCTATTGCACCTAT
LuxS-F2 AAGAAGTTATCGTCGAAA
LuxS-F3 AATCCTACTGACCTATTT
LuxS-R4 TAGTGGCAACACGGTGAA
LuxS-R5 TGAAAACCTGTTCGACAG
LuxS-R6 ATAATGGCAATGGTTAC
LuxS-R7 GTACCTTACAATCAAGATGTT
RofA-F1 TCTTGAGCTAATGCAACCGT
RofA-F2 GAATCCGTTAGGAGATGA
RofA-F3 GTTTCGATAATATCATGG
RofA-F4 AAAGGATGTGTAAATTGG
RofA-F5 ACAAGGTTTCCAAATAAG
RofA-R6 AAGCAATTAACATAAGCG
RofA-R7 TCTGCAACATTTTATTCC
RofA-R8 GGCATTAAAGTTTATGAC
RofA-R9 TAGGAAGAGAGGTCCCTT
RofA-R10 GAACTTGAATCTGGATTTATTG
RopA-F1 TCTTGTCCTGCAAATACGTC
RopA-F2 TCTTCTTGAGTTGTACCA
RopA-F3 CTCAACACCATCAACTGA
Primer name Sequence (59–39)
RopA-F4 GATTTGTAGCTTTGTTTTC
RopA-R5 TTAAGGAACAAAACGTACAAG
RopA-R6 ATGTTGACACACTTGAAG
RopA-R7 TGTTGTGTCAATGGAAAA
RopA-R8 ATGCCATAGTCATCCGTT
RopA-R9 AATCCTTTCTTTGATAGTTTATC
doi:10.1371/journal.pone.0004102.t001
Table 1. cont.
Figure 1. Mutation in ropB results in truncation of the RopB
protein and abrogation of SpeB expression. (A) Schematic
representation of the RopB protein expressed by GAS strains 5448
and 5628. In 5628, white region represent homology to 5448, shaded
region indicates unique protein sequence in 5628. (B) Western blot for
SpeB using overnight culture supernatants. (C) SpeB activity assay using
azocasein substrate.
doi:10.1371/journal.pone.0004102.g001
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passage in the mouse subcutaneous infection model.
SpeB is the principal target of RopB regulation in vivo
Microarray analysis was performed on in vivo-derived RNA from
the well characterized GAS strain 5448 and its derivative
5448R2, containing the mutated ropB allele from 5628. Fourty-
seven genes were found to be down-regulated and 52 genes were
found to be up-regulated in 5448R2 greater than 2-fold (P,0.05).
The most strongly down-regulated genes in 5448R2 are members
of the SpeB operon, as would be expected from the lack of SpeB
expression and activity in 5628 (Fig. 3). In addition to the SpeB
operon, genes of the streptolysin S operon were also found to be
strongly down-regulated in the ropB mutant strain. Apart from the
gene encoding the superantigen SmeZ, there was an absence of
virulence-related genes found to be strongly up-regulated in the
strain 5448R2, which expressed the truncated RopB.
RopB is required for virulence in systemic infection
To determine the effect of ropB mutation on virulence,
C57BL6/J mice were subjected to intraperitoneal infection with
mid-logarithmic phase bacteria. GAS strain 5628R+ expressing a
full length RopB showed increased virulence compared to the
strain 5628 with a truncated RopB (Figure 4A). Strain
5628RDSpeB containing a full-length RopB but lacking SpeB
also showed reduced virulence, suggesting that the reduced
Figure 2. RopB mutation does not affect in vitro growth, hemolytic activity, extracellular DNase activity or resistance to neutrophil
killing. (A) OD600 of in vitro grown bacterial cultures in THB. (B) Hemolysis of red blood cells by bacterial culture supernatants. (C) Degradation of calf
thymus DNA by bacterial culture supernatants, run on a 1% agarose gel. (D) Bacterial survival after 30 min incubation with human neutrophils.
doi:10.1371/journal.pone.0004102.g002
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expression in this strain. Virulence was also examined in an
intravenous model of systemic infection. The well characterized
strain 5448 and its isogenic mutant 5448R2, containing the ropB
allele from 5628, were further included to examine the effect of
this allelic variation in a well-characterized virulent strain of GAS.
The two strains containing a truncated RopB (5628 and 5448R2)
demonstrated similarly reduced virulence compared to the two
strains containing a full-length RopB (5628R+ and 5448) (Fig. 4B),
confirming that inactivation of RopB results in decreased virulence
in systemic infection.
Discussion
The cumulative contribution of the secreted cysteine protease
SpeB to the pathogenesis of invasive GAS infection is at present
unclear, and studies in various GAS serotypes and animal models
have produced varying results [19–21]. In the globally-dissemi-
nated clonal M1T1 serotype associated with epidemic invasive
GAS infection, an inverse relationship has been found between
SpeB activity and clinical disease severity [8]. Recently, we and
others have found a connection between inactivation of SpeB
through mutation in the two-component regulatory system covR/
S and development of invasive disease in the murine model
[37,38]. In this study, we have investigated a second mechanism of
inactivation of SpeB, namely through truncation of the regulator
RopB. We have shown that in M1T1 GAS, when the covR/S locus
is intact and DNase Sda1 activity is unaffected, ropB point
mutation results in reduced virulence in vivo, despite inactivation of
SpeB activity.
The SpeB-negative, serotype M1T1 clinical isolate 5628 was
used to investigate the role of RopB in virulence. RopB has
previously been shown to be necessary for SpeB production
[23,24] as well as regulation of other GAS virulence factors [25–
29]. The M1T1 strain 5628 contains a point mutation in the ropB
gene that results in a truncation of the last 110 amino acids of the
280 amino acid protein. Restoration of full-length RopB in
5628R+ resulted in gaining SpeB expression, but did not result in
changes in hemolysis, DNase activity or resistance to killing by
neutrophils. RopB mutation in this particular strain does not result
in the kind of global phenotypic change found with covR/S
mutation where differential expression was observed of multiple
genes encoding virulence determinants, including sic, ska, slo, speA,
speJ, scpC and the hyaluronic acid synthesis operon [37] which
were all unaffected in the ropB mutant examined in this work.
Recently, we have demonstrated that WT, SpeB-positive
bacteria undergo a phase-shift to a SpeB-negative phenotype after
subcutaneous infection of mice [17]. This phase switch was
observed to be the result of mutations in the two-component
regulatory system covR/S [38]. CovR/S is a global regulator,
whose inactivation is linked to an invasive phenotype and involves
up-regulation of many genes encoding virulence factors such as
streptodornase, streptokinase, streptolysin O, streptococcal inhib-
itor of complement and the hyaluronic acid capsule synthesis
operon [37]. Of the down-regulated genes in CovR/S mutant
strains, SpeB would appear to be one of the most important due to
its ability to degrade many host and self-proteins. It is the loss of
SpeB expression in these mutant bacteria that is hypothesized to
allow the invasive spread of GAS by sparing from SpeB
degradation self-proteins involved in plasminogen accumulation
and activation [42]. In this study we found that SpeB-positive
bacteria with a restored RopB reverted to a SpeB-negative
phenotype on subcutaneous infection. Furthermore, the switch to
a SpeB-negative phenotype appeared to occur exclusively through
mutations in covR/S. This result suggests that covR/S mutations are
the predominant method of phenotypic switching in GAS and that
ropB mutation is not readily selected for in vivo. This leads to the
conclusion that ropB mutation in 5628 does not represent a similar
mechanism to covR/S mutation and may (a) be an incidental
occurrence or (b) arise secondary to different selection pressures
than those associated with the shift to invasive infection.
Microarray analysis was conducted using in vivo-derived RNA,
since the transcriptome of bacteria grown in vitro may differ greatly
Figure 3. Microarray analysis emphasizes the down-regulation of the SpeB operon. The figure shows the top 10 genes up- and down-
regulated in the ropB mutant bacteria compared to WT when the bacteria are inoculated in vivo (P,0.05). The values plotted represent log ratios (log
mutant/WT), and genes co-clustered in operons are highlighted (black bars, SpeB operon; white bars, SLS operon).
doi:10.1371/journal.pone.0004102.g003
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Implantation of tissue cages allows for bacteria to be grown in an
in vivo environment for 24 hours prior to recovery and RNA
extraction. The microarray data showed members of the SpeB
operon to be the most strongly down-regulated genes following
inactivation of RopB. This finding supported the in vitro and in vivo
data that suggested SpeB is the main target of RopB regulation in
this strain.
Virulence studies utilizing systemic models of infection showed
that a full-length RopB was required for virulence. The clinical
isolate 5628 expressing a truncated RopB, as well as the allelic
exchange mutant 5448R2 also expressing the truncated RopB
from 5628, showed reduced virulence compared to strains
containing a full-length RopB. These data illustrate the necessity
for an intact RopB for full virulence in vivo. In addition, the strain
5628RDSpeB expressing an intact RopB but lacking SpeB showed
similarly reduced virulence to the strain with a truncated RopB.
While the down-regulation of the streptolysin S operon may
contribute to the reduced virulence, this finding implies that the
loss of SpeB in this strain is the main cause of the lack of virulence
exhibited. This finding leads to the conclusion that inactivation of
SpeB alone is not sufficient to initiate invasive disease. Moreover,
these data suggest that SpeB loss, only in the context of mutation
of the covR/S regulatory circuit, promotes invasion. Of note, the
additional virulence factors streptokinase and M1 protein, are both
up-regulated in covR/S mutant M1T1 strains [37], but not in the
ropB mutant under investigation in this study. Streptokinase and
M1 protein are believed to play a role in the accumulation of host
plasmin at the GAS cell surface, a process which is thought to
accentuate invasive disease [5,42,43].
Together these data provide evidence of RopB’s role in
virulence. In M1T1 GAS, an intact RopB and efficient SpeB
production are necessary for systemic infection.
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Figure 4. RopB and SpeB-negative bacteria show reduced virulence in systemic infection models. (A) Intraperitoneal infection of
C57BL6/J mice with 5610
7 cfu of GAS strains with 5% mucin. (B) Intravenous challenge of C57BL6/J mice with 2610
8 cfu of GAS strains.
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